EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Sleep Quality in Hemodialysis Patients According to Renal Anemia Treatment Outcomes

Elif Basaran, Cihan Uysal

Advances in Modern Biomedicine · 2025

DOI: 10.64229/mybdry40 ↗
AbstractBibliografische Angaben

Abstract

Backgound: We assessed the impact of renal anemia treatment on sleep quality among hemodialysis (HD) patients. Methods: To be included in the study, patients had to have received epoetin (EPO) therapy within the past year. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), with poor sleepers defined as those with a global PSQI score > 5. The target hemoglobin level (THb) was defined as a hemoglobin (Hb) level greater than 11.0 g/dL in the three months preceding the sleep survey. Results: A total of 78 patients were included, with a median age of 59.0 years. The mean HD vintage was 50.5 months. THb levels were achieved in 43 patients (55.1%), while 46 patients (59.0%) were identified as poor sleepers. Median PSQI score was 6 (4–11) in patients who achieved THb, compared with 7 (4–9) in those who did not (p=0.217). Mean Hb level was 11.2±1.3 g/dL among poor sleepers and 11.3±1.2 g/dL among non-poor sleepers (p=0.603). There was no significant correlation between PSQI score and Hb level (p=0.955). The frequency of poor sleepers was significantly higher in patients receiving EPO therapy (68.0%) compared to those not receiving EPO therapy (42.8%) (p=0.027). Furthermore, EPO use was identified as an independent risk factor for poor sleep quality (OR: 2.822, 95% CI: 1.029–7.737). Neither Hb level nor achieving THb were found to be independent predictors of poor sleep quality. Conclusion: Successful anemia treatment did not have a positive impact on sleep quality among HD patients.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →